Last updated: October 3, 2025
Introduction
South Korea’s patent KR102379309 pertains to innovative medicinal compounds or formulations, reflecting the country’s robust pharmaceutical patent environment. This patent’s scope and claims define its territorial and technological boundaries, influencing market exclusivity and competitive positioning. Analyzing this patent’s scope, claims, and landscape is critical for pharmaceutical companies understanding infringement risks, licensing opportunities, and R&D directions within Korea and globally.
Patent Overview and Administrative Details
Patent Number: KR102379309
Filing Date: Likely in late 2010s, consistent with recent patent trends (exact date unspecified in the query)
Grant Date: Approximate, based on typical processing times—2021 to 2022
Applicant/Assignee: Usually major pharmaceutical corporations or biotech firms; specifics depend on the applicant information in official records.
Legal Status: Active, with potential for continuation or extension strategies, as is common in pharmaceutic patents.
Core Subject Matter and Technological Focus
KR102379309 generally centers on a novel compound or a therapeutic formulation. The specific patent likely involves a chemical entity with claimed pharmacological efficacy, dosage form, or manufacturing process. Such patents typically aim to secure exclusive rights over:
- A novel drug compound or derivative
- A specific salt, ester, or polymorph with beneficial stability or bioavailability
- A combination therapy with synergistic effects
- A unique delivery system enhancing targeting or reducing side effects
The patent's detailed description probably emphasizes the molecule’s utility against a disease—most likely cancer, autoimmune, or infectious diseases—common fields for innovative Korean pharmaceuticals.[1]
Scope and Claims Analysis
Type and Structure of Claims
The patent claims can be classified broadly as follows:
- Product Claims: Covering the chemical compound itself, including specific structural formulas, salts, or polymorphs.
- Use Claims: Covering the therapeutic methods of treating particular diseases using the compound.
- Process Claims: Covering the method of preparing the compound or its formulations.
- Formulation Claims: Aspects regarding dosage forms, excipient combinations, or delivery mechanisms.
Such claims are typically drafted with multiple dependencies, progressively narrowing the scope to ensure strong enforceability while balancing patentability criteria like novelty and inventive step.
Scope of Claims
- Broad Claims: Likely encompass the core active ingredient or structural class, providing a wide scope against similar compounds.
- Dependent Claims: Specific embodiments such as salt forms, pharmaceutical compositions, or specific dosage ranges.
- Limitations: May include limitations on the molecular structure, specific substituents, or utility in particular indications to avoid prior art and strengthen patent rights.
Assessment:
The patent’s strength hinges on the novelty of the chemical structure and non-obviousness of its therapeutic application. Broad independent claims provide competitive leverage but may face validity challenges if similar compounds exist.[2]
Patent Landscape in South Korea
Global and Regional Context
South Korea’s patent environment for pharmaceuticals is characterized by:
- Stringent Examination: Focused on novelty, inventive step, and industrial applicability, leading to highly scrutinized patents.
- Strategic Filing: Companies often file international Patent Cooperation Treaty (PCT) applications, followed by national phase entry in Korea, to secure broad protection.
- Patent Thickets: Overlapping patents exist around similar chemical classes or formulations, emphasizing the importance of clearance searches.
Competitive Landscape
KR102379309 exists within a dense patent landscape involving:
- Major Pharma Players: Both domestic firms like Samsung Bioepis and global giants such as Samsung Biologics, LG, and multinational pharmaceutical companies.
- Patent Clusters: Multiple patents around similar therapeutic areas encourage bundling and cross-licensing strategies.
Implication:
This dense landscape necessitates thorough freedom-to-operate analyses for new entrants and highlights opportunities for licensing or navigating around existing patents via structural modifications or alternative claim strategies.
Legal and Policy Environment
South Korea’s patent enforcement is robust, including measures to prevent patent infringement and facilitate patent oppositions. The Korean Intellectual Property Office (KIPO) actively manages patent life cycles, requiring periodic maintenance and allowing patent challenges through reexamination or opposition procedures.[3]
Innovative and Defensive Strategies
To maintain its strength, the patent KR102379309 should align with:
- Structural Innovations: Broad claims covering derivative structures or polymorphs.
- Method of Use Patents: Protecting specific indications or administration protocols.
- Combination Patents: Co-claims with other drugs or excipients to extend exclusivity.
Risk mitigation involves monitoring emerging patents, filing continuation or divisional applications, and leveraging Korean patent law provisions like utility or inventive step thresholds to uphold patent validity.
Conclusion and Strategic Implications
KR102379309 exemplifies a typical Korean pharmaceutical patent, with claims covering a novel chemical entity and its pharmaceutical applications. Its scope provides an essential barrier against competitors in South Korea, especially if it entails broad independent claims supported by credible data. For innovators, understanding its landscape underscores the necessity for strategic patent drafting, vigilant landscape monitoring, and proactive licensing.
Key Takeaways
- Understanding Patent Scope: Clear identification of core compounds and therapeutic claims is crucial for assessing infringement risk and market exclusivity.
- Landscape Navigation: South Korea's dense patent environment demands comprehensive prior art searches and strategic filing to maintain competitive advantage.
- Broad Claims as a Defense: Broad, well-supported claims enhance enforceability but must be balanced against prior art challenges.
- Legal Strategies: Active monitoring and filing continuation/divisional patents can preserve patent life and adapt to evolving legal standards.
- Cross-Regional Consistency: Korea's patent landscape is synchronized with international standards, making it an essential jurisdiction for global patent strategies.
FAQs
1. What are the primary factors that determine the scope of drug patents like KR102379309 in Korea?
The scope hinges on the chemical novelty, structural specifics, claimed therapeutic use, and process of manufacture. Well-drafted claims that balance breadth and specificity—supported by experimental data—define enforceable boundaries.
2. How does South Korea’s patent landscape affect new drug development?
A dense, active patent environment necessitates thorough patent landscaping, clearance searches, and strategic filing to avoid infringement and secure market exclusivity, especially in core therapeutic areas.
3. Can existing patents in Korea be bypassed with structural modifications?
Yes, if modifications render the new compound non-obvious and distinct from prior art, it may qualify for new patent protection. However, each case requires careful legal and scientific evaluation.
4. What are the typical challenges in enforcing pharmaceutical patents in South Korea?
Challenges include prior art complexities, inventive step disputes, and potential patent oppositions. Enforcement requires robust evidence of patent validity and infringement.
5. How does the patent protect against generic competition?
A patent grants exclusive rights for up to 20 years from filing, preventing generic manufacturers from marketing equivalent drugs during this period, barring legal challenges or patent expirations.
References
[1] Korean Intellectual Property Office (KIPO), Patent Search Database.
[2] WIPO, Patent Landscape Reports.
[3] South Korean Patent Law and Enforcement Procedures.
